Showing results (751-760 of 769) with videos related to

Sort By:
Pageof 77
Transfusion|May 15, 2025
Differences in the product characteristics and clinical use of granulocytes for transfusion: The BEST Collaborative studyLorna Cain, Charles Lafrance, Suzy Morton, et al.
Journal of Medicinal Chemistry|September 20, 2008
Identification of 4-(2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(3S)-3-piperidinylmethyl]oxy}-1H-imidazo[4,5-c]pyridin-4-yl)-2-methyl-3-butyn-2-ol (GSK690693), a novel inhibitor of AKT kinaseDirk A Heerding, Nelson Rhodes, Jack D Leber, et al.
Neuroimage. Clinical|July 3, 2021
Neuroimaging in Functional Neurological Disorder: State of the Field and Research AgendaDavid L Perez, Timothy R Nicholson, Ali A Asadi-Pooya, et al.
Mabs|November 22, 2021
Isolation and characterization of monoclonal antibodies against human carbonic anhydrase-IXAnne E G Lenferink, Paul C McDonald, Christiane Cantin, et al.
Bioscience|March 31, 2018
Worldwide Engagement for Digitizing Biocollections (WeDigBio): The Biocollections Community's Citizen-Science Space on the CalendarElizabeth R Ellwood, Paul Kimberly, Robert Guralnick, et al.
JMIR Research Protocols|May 31, 2017
Diagnosis, Prevalence, Awareness, Treatment, Prevention, and Control of Hypertension in Cameroon: Protocol for a Systematic Review and Meta-Analysis of Clinic-Based and Community-Based StudiesBarthelemy Kuate Defo, Jean Claude Mbanya, Jean-Claude Tardif, et al.
ACS Medicinal Chemistry Letters|December 21, 2019
Discovery of Potent and Selective Antibody-Drug Conjugates with Eg5 Inhibitors through Linker and Payload OptimizationAlexei S Karpov, Cristina M Nieto-Oberhuber, Tinya Abrams, et al.
Iscience|October 10, 2022
A solution to the challenges of interdisciplinary aggregation and use of specimen-level trait dataMeghan A Balk, John Deck, Kitty F Emery, et al.
Science Translational Medicine|May 13, 2021
Antibody semorinemab reduces tau pathology in a transgenic mouse model and engages tau in patients with Alzheimer's diseaseGai Ayalon, Seung-Hye Lee, Oskar Adolfsson, et al.
Journal of Medicinal Chemistry|May 18, 2026
Antibody-Mediated Delivery of BRM/BRG1 Protein Degraders Affords Strong Antitumor Efficacy in Multiple BRM-Dependent Non-Small Cell Lung Cancer Xenograft ModelsSummer A Baker Dockrey, Pravin Chandra, Huifen Chen, et al.
Pageof 77